195 related articles for article (PubMed ID: 32818538)
1. Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety.
Chatzitaki AT; Jesus S; Karavasili C; Andreadis D; Fatouros DG; Borges O
Int J Pharm; 2020 Nov; 589():119776. PubMed ID: 32818538
[TBL] [Abstract][Full Text] [Related]
2. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
3. PLGA/DPPC/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment.
Karavasili C; Bouropoulos N; Sygellou L; Amanatiadou EP; Vizirianakis IS; Fatouros DG
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():1053-1062. PubMed ID: 26652464
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V
Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435
[TBL] [Abstract][Full Text] [Related]
5. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
6. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin.
Akel H; Csóka I; Ambrus R; Bocsik A; Gróf I; Mészáros M; Szecskó A; Kozma G; Veszelka S; Deli MA; Kónya Z; Katona G
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948054
[TBL] [Abstract][Full Text] [Related]
9. Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design.
Salem HF; Ali AA; Rabea YK; Abo El-Ela FI; Khallaf RA
J Pharm Sci; 2023 Feb; 112(2):544-561. PubMed ID: 36063878
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
11. Improved oral delivery of insulin by PLGA nanoparticles coated with 5
Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L
Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Jafarieh O; Md S; Ali M; Baboota S; Sahni JK; Kumari B; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
[TBL] [Abstract][Full Text] [Related]
13. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
14. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
15. Bicistronic DNA vaccine macromolecule complexed with poly lactic-co-glycolic acid-chitosan nanoparticles enhanced the mucosal immunity of Labeo rohita against Edwardsiella tarda infection.
Leya T; Ahmad I; Sharma R; Tripathi G; Kurcheti PP; Rajendran KV; Bedekar MK
Int J Biol Macromol; 2020 Aug; 156():928-937. PubMed ID: 32289420
[TBL] [Abstract][Full Text] [Related]
16. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
[TBL] [Abstract][Full Text] [Related]
17. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
18. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
19. Development and optimization of pH-responsive PLGA-chitosan nanoparticles for triggered release of antimicrobials.
Pola CC; Moraes ARF; Medeiros EAA; Teófilo RF; Soares NFF; Gomes CL
Food Chem; 2019 Oct; 295():671-679. PubMed ID: 31174811
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
